American Shared Hospital Services (NYSE American: AMS) announced its financial results for the fourth quarter and full year ended December 31, 2025. The company reported total revenue of $28.1 million for the full year, a slight decrease from $28.3 million in 2024. The net loss attributable to American Shared Hospital Services was $1.6 million, or $0.23 per diluted share, compared to a net income of $2.2 million, or $0.33 per diluted share, in the previous year. The decline in revenue was primarily attributed to the expiration of three Gamma Knife agreements and lower proton therapy volumes. In the fourth quarter alone, revenue decreased by 14.8% to $7.7 million compared to $9.1 million in the prior year period. The direct patient care services segment represented 63% of total sales in Q4 2025, reflecting a strategic shift towards expanding this segment. The company also announced a seven-year extension of its Proton Therapy lease agreement with Orlando Health, which is expected to enhance its operational capabilities and revenue potential moving forward. Despite the challenges faced in 2025, the company remains focused on optimizing operations and expanding patient access to advanced radiation therapy treatment options.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.